Frederick Telling has served as Director of Oragenics since 2010 and was elected Chairman of the Board of Directors on February 4, 2011 and was appointed as Executive Chairman on May 2, 2021 following the resignation of Dr. Joslyn, the Company’s former President and Chief Executive Officer.

Dr. Telling also serves on the boards of various civic and non-profit organizations. Dr. Telling retired from Pfizer Inc. in 2007 after 30 years of service as their Corporate Vice President and Vice President of Corporate Strategic Planning and Policy. He focused on product licensing, mergers and acquisitions, and global health policy.

Telling holds a B.A. in History and Economics from Hamilton College, an M.A. in Industrial and Labor Relations, and a PhD in Economics and Public Policy from Cornell University.